Prognostic value of [18F]FDG-PET imaging in small cell lung cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 1, 2003, Pages 78-84

  Pandit, Neeta ^a   Gonen, Mithat ^a   Krug, Lee ^a   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

FDG; PET; Small cell lung cancer; Staging; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; LUNG SMALL CELL CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; LABORATORY DIAGNOSIS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SMALL CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME; UNITED STATES; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 0038546390     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0937-8     Document Type: Article

References (24)

1. Boring CC, Squire TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994; 44:7-26.
2. Ihde D. Chemotherapy of lung cancer. N Engl J Med 1992; 32:1434-1441.
3. Pasemans M, Sculier JP, Lecombe J, et al. Prognostic factors for patients with small cell lung carcinoma. Cancer 2000; 89:523-533.
4. Ihde DC, Glatstein E, Pass HI. Small cell lung cancer. In: De Vita VT Jr, Hellman S, Rosenberg SA. Cancer. Principles and practice of oncology, 5th edn. Philadelphia: Lippincott-Raven; 1997:911-950.
5. Webb RW, Gatsonis C, Zehrhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of radiologic diagnostic oncology group. Radiology 1991; 178:705-713.
6. Mcloud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323.
7. Dewan NA, Shehan CJ, Reeb SD, Gobar LS. Likelihood of malignancy in solitary pulmonary nodule. Chest 1997; 112:416-422.
8. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1-3cm) and large (>3 cm) lymph node lesions. Chest 2000; 117:773-778.
9. Farrell MA, McAdams HP, Herndon JE. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000; 215:886-890.
10. Pieterman RM, John WG, Putten V, et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343:254-261.
11. Gambhir SS, Shepherd JE, Shah BD, et al. Analytical decision model for the cost effective management of solitary pulmonary lesions. Chest 1995; 108:441-446.
12. Patz EF, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR 2000; 174:769-774.
13. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793.
14. 201Tl chloride. Nuc Med Commun 1997; 18:341-345.
15. Vaccarilli M, Lococo A, Fabiani F, et al. Clinical diagnostic application of In 111 DTPA - octreotide scintigraphy in small cell lung cancer. Tumori 2000; 86:224-228.
16. Takekawa H, Shinano H, Tsukamoto E, et al. Technetium 99m tetrofosmin imaging in lung cancer: relationship with histopathology. Ann Nucl Med 1999; 13:71-75.
17. Groshar D, Seagall GM. FDG-PET imaging in small cell lung cancer [abstract] Clin Pos Imag 1999; 2:330.
18. Hauber HP, Bohuslavizki KH, Lund CH, et al. Positron emission tomography in the staging of small cell lung cancer - a preliminary study. Chest 2001; 119:950-954.
19. Schumacher T, Brink I, Mix M, et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med 2001; 28:483-488.
20. Chin R, McCain TW, Miller AA, et al. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer 2002; 37:1-6.
21. Gonen M, Panageas KS, Larson SM. Statistical issues in the analysis of diagnostic imaging experiments with multiple observations per patient. Radiology 2001; 221:763-767.
22. Efron B, Tibshirani R. Introduction to the bootstrap. New York: Chapman and Hall, 1993.
23. Matthews MJ. Problems in morphology and behavior of bronchopulmonary malignant diseases. In: Israel L, Chahinian AP, eds. Lung cancer; natural history, prognosis and therapy. New York: Academic Press; 1976:23-62.
24. Giannone L, Johnson DH, Hande KR, et al. Favorable prognosis of brain metastasis in small cell carcinoma of lung. Ann Intern Med 1987; 106:386-389.